Advocacy intelligence hub — real-time data for patient organizations
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center — PHASE2, PHASE3
Ozlem Goker-Alpan — PHASE2
Ultragenyx Pharmaceutical Inc — PHASE2, PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs